Sarcoma News & Features

Cutaneous melanoma begets cutaneous melanoma

Delicia Honen Yard January 06, 2012

Continued skin surveillance is important for survivors of cutaneous melanoma (CM), indicate findings showing that this is the most common second primary cancer among persons with a first CM.
 

Cancer risk doubles for organ-transplant recipients

Delicia Honen Yard November 21, 2011

Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have twice as great a risk for diverse infection-related and unrelated cancers.
 

Gene discovery may lead to cure for rare vascular cancer

Delicia Honen Yard September 22, 2011

A specific genetic alteration has been identified as a defining feature of epithelioid hemangioendothelioma (EHE), a vascular sarcoma that strikes about 100 people nationwide each year.
 

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

July 14, 2011

A look at the following clinical trial: Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
 

New drug helps control rare sarcoma disease

Delicia Honen Yard June 22, 2011

The experimental agent cediranib shrank tumors in more than half of study subjects afflicted with alveolar soft part sarcoma (ASPS).
 

Childhood cancer survivors more likely to have future GI problems

Delicia Honen Yard June 01, 2011

People who underwent cancer therapy as children have a heightened risk of developing gastrointestinal (GI) complications later in life, a new study shows.
 

Sperm retrieval offers fertility hope

April 01, 2011

Adult men who were thought to be rendered sterile due to chemotherapy for childhood cancer may be able to reproduce with the help of a surgical technique that has recently been shown to locate and extract viable sperm.
 

Heat helps boosts antitumor effect of chemotherapy

May 18, 2010

Heating the area around soft tissue sarcoma increases the benefit of chemotherapy, according to a study published in Lancet Oncology 2010 Apr 28 [Epub ahead of print].
 

Case study: Solitary plasmacytoma of the scapula

Benjamin JF Dean; Colin Chu; David Noyes; Duncan Whitwell January 22, 2010

A case study of a solitary plasmacytoma of the scapula involves a radical curative resection
 

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets

FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions